Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 399 entries
View as:

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04484532 Org: User:
Start: 10/17/17 End: 06/07/22 Due: 06/07/23

Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03881735 Org: User:
Start: 12/02/19 End: 11/19/22 Due: 11/19/23

Experimental Tobacco Marketplace in Regulating Flavored Tobacco Products in Menthol Cigarette Smokers

Phase: N/A Priority: Normal
NCT ID: NCT03897530 Org: User:
Start: 06/30/19 End: 07/20/23 Due: 07/20/24

Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03685695 Org: User:
Start: 06/27/17 End: 07/30/20 Due: 07/30/21

APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion

Phase: N/A Priority: Normal
NCT ID: NCT04919629 Org: User:
Start: 04/27/23 End: 04/30/27 Due: 04/30/28

Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice

Phase: N/A Priority: Normal
NCT ID: NCT04297384 Org: User:
Start: 02/06/19 End: 08/30/22 Due: 08/30/23

Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00023985 Org: User:
Start: 01/31/01 End: 08/31/03 Due: 08/31/04

Study for the Liquid Chromatography-mass Spectrometry (LC-MS/MS) Assessment of Oxidative DNA Damage in Relation to Antioxidant Usage

Phase: N/A Priority: Normal
NCT ID: NCT01038024 Org: User:
Start: 01/31/10 End: 07/31/12 Due: 07/31/13

Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission

Phase: N/A Priority: Normal
NCT ID: NCT01982487 Org: User:
Start: 12/31/13 End: - Due: -

Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial

Phase: N/A Priority: Normal
NCT ID: NCT06563388 Org: User:
Start: 09/18/24 End: 09/18/32 Due: 09/18/33

Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers

Phase: N/A Priority: Normal
NCT ID: NCT05825001 Org: User:
Start: 09/15/24 End: 09/01/25 Due: 09/01/26

Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients

Phase: N/A Priority: Normal
NCT ID: NCT05893940 Org: User:
Start: 08/14/23 End: 09/01/26 Due: 09/01/27

Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00559481 Org: User:
Start: 10/31/07 End: - Due: -

Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02287727 Org: User:
Start: 03/31/15 End: - Due: -

Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00096018 Org: User:
Start: 05/31/02 End: 05/31/12 Due: 05/31/13

Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06670976 Org: User:
Start: 05/15/26 End: 11/15/29 Due: 11/15/30

Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03751436 Org: User:
Start: 08/02/19 End: 08/11/23 Due: 08/11/24

Acceptability of Less Harmful Alternatives to Cigarettes

Phase: N/A Priority: Normal
NCT ID: NCT00957424 Org: User:
Start: 06/30/09 End: 11/30/11 Due: 11/30/12

Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00244985 Org: User:
Start: 09/30/05 End: 12/31/12 Due: 12/31/13

Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03735095 Org: User:
Start: 02/12/20 End: 07/26/24 Due: 07/26/25

Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04530812 Org: User:
Start: 08/24/20 End: 08/30/21 Due: 08/30/22

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01892930 Org: User:
Start: 07/11/13 End: 12/30/16 Due: 12/30/17

Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00054171 Org: User:
Start: 02/28/99 End: - Due: -

Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT02953457 Org: User:
Start: 06/29/17 End: 08/15/24 Due: 08/15/25

Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06798701 Org: User:
Start: 06/15/25 End: 01/30/26 Due: 01/30/27